Chuangyuan Biotechnology won the 'Source Innovation Application' award at the Natural New Forces Innovative Raw Materials Selection Event.

In April 2022, Zhi Ti Bridge initiated the "5th Natural New Forces Innovation Raw Material Selection Activity," which lasted for a total of 2 months, covering a wide range of raw materials and process technologies. The "Multiple Probiotics Segmented Solid Fermentation Postbiotics" project by Chuangyuan Biotechnology made a significant appearance, standing out among 136 participating projects and 102 participating companies, and won the "Source Innovation Application" award.Multiple Probiotics Segmented Solid Fermentation PostbioticsThis project, which won the "Source Innovation Application" award, is developed using Chuangyuan Biotechnology's internationally advanced segmented solid fermentation technology for probiotics. The various probiotics used in this technology are sourced from healthy human intestines and traditional Chinese fermented foods, selected for their suitability for the Chinese constitution. They belong to the company's proprietary core strains. By simulating the characteristics of core intestinal strains, a combination of aerobic, facultative anaerobic, and anaerobic bacteria was selected to mimic the characteristics of different stages of human digestion during fermentation. The final product can simulate the effects of fecal microbiota transplantation to rebuild a normal intestinal microecological structure.

As a pioneer and practitioner in the health industry, Chuangyuan Biotechnology is committed to exploring and researching the intestinal microecology field based on internationally advanced segmented solid fermentation technology for multiple probiotics. The company actively collaborates with several renowned universities and authoritative research institutions both domestically and internationally, including Harvard University, National University of Singapore, Tianjin University of Science and Technology, Shenzhen Tsinghua University Research Institute, and the National Key Laboratory of Food Nutrition and Safety co-established by provincial and ministerial departments, to jointly build research and development platforms, empower technological innovation, and lay a solid foundation for the development of 3.0 probiotic microecological preparations, while also providing strong support and core competitiveness for application-end enterprises. This recognition on the list is a significant acknowledgment from Zhi Ti Bridge and the probiotic industry towards Chuangyuan Biotechnology.Zhi Ti Bridgeand the probiotic industry is a significant recognition of Chuangyuan Biotechnology.

The project that won the "Source Innovation Application" award is the "Multiple Probiotics Segmented Solid Fermentation Postbiotics" developed by Chuangyuan Biotechnology using internationally advanced segmented solid fermentation technology for probiotics. The various probiotics used in this technology are sourced from healthy human intestines and traditional Chinese fermented foods, selected for their suitability for the Chinese constitution. They belong to the company's proprietary core strains. By simulating the characteristics of core intestinal strains, a combination of aerobic, facultative anaerobic, and anaerobic bacteria was selected to mimic the characteristics of different stages of human digestion during fermentation. The final product can simulate the effects of fecal microbiota transplantation to rebuild a normal intestinal microecological structure.

At the same time, this technology utilizes an industrially feasible bionic digestion system constructed in vitro for fermentation, applying internationally advanced patented segmented solid fermentation technology for multiple probiotics. Various probiotics are introduced into the fermentation substrate at different times according to their strain characteristics, fermenting without free water. The fermented products are then dried and crushed, ultimately obtaining postbiotic probiotics.Ecological Food.

Based on continuous in-depth research on the company's core technology and the expansion of application fields, Chuangyuan Biotechnology, as a pioneer and practitioner of segmented solid fermentation technology for probiotics in China, not only provides postbiotic raw materials with core patented technology but also possesses production qualifications for a full range of special dietary foods, dedicated to providing customers with comprehensive supply chain product solutions. The company has now formed strategic partnerships with several leading enterprises across various domestic industries.Special Dietary FoodsThe company has now formed strategic partnerships with several leading enterprises across various domestic industries, including Mengniu Yashili, Biyuan, Xiu Zheng Pharmaceutical, China National Pharmaceutical Group, Liaoning Provincial Hospital of Traditional Chinese Medicine, Minzhong Health Checkup, Qingyan Boshih, Changqing (China), and Tian Shi.Strategic PartnershipsThe company's second-phase production base and key laboratory project for microecological preparations is currently under construction, covering an area of 51 acres, with a building area of 25,000 square meters and a total investment of 250 million yuan, expected to be completed and put into production by the end of 2022.

The health industry is moving into the "fast lane" under the strategic background of "Healthy China," bringing certainty in market space and business environment to enterprises, making the prospects of national health initiatives as vast as the stars and the sea. A new round of industrial transformation is on the horizon, with biotechnology becoming an important enabling technology for accelerating economic transformation and development. Chuangyuan Biotechnology always adheres to the corporate mission of "leading the return of health value and improving the quality of human life" to benefit national health. The company will combine its core technological advantages, raw material and product characteristics, and trends in consumer demand to continuously enhance research and production capabilities, creating more and higher-quality health products and services, allowing customers and consumers to truly experience the value of 3.0 probiotic microecological preparations, and contributing to the great development of the Healthy China strategy.

About Natural New Forces

Natural New Forces (formerly known as the "New Power" Innovation Selection) is a competition established by Zhi Ti Bridge in 2018, aimed at discovering the innovative potential of enterprises in the natural health industry through a comprehensive competition selection mechanism, empowering the entire natural health industry.
The Natural New Forces Innovation Raw Material Selection Activity was officially launched in 2022, while Zhi Ti Bridge made a significant upgrade to the 5th Natural New Forces Selection Activity, dividing it into an innovation raw material selection in the first half of the year and an innovation product selection in the second half, two activities targeting different types of enterprises. The activity aims to discover, showcase, and display innovative raw materials and products within the industry, establish benchmark enterprises and quality products, highlight the innovative landscape of the natural health industry, and assist in the innovation and development of the industry.